1. Home
  2. PUBM vs FTH Comparison

PUBM vs FTH Comparison

Compare PUBM & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PubMatic Inc.

PUBM

PubMatic Inc.

HOLD

Current Price

$16.08

Market Cap

772.5M

Sector

Technology

ML Signal

HOLD

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

N/A

Current Price

$36.21

Market Cap

835.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PUBM
FTH
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
772.5M
835.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PUBM
FTH
Price
$16.08
$36.21
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$12.43
N/A
AVG Volume (30 Days)
642.4K
279.9K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$282,926,000.00
N/A
Revenue This Year
$3.44
N/A
Revenue Next Year
$7.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.15
$17.50
52 Week High
$18.44
$42.14

Technical Indicators

Market Signals
Indicator
PUBM
FTH
Relative Strength Index (RSI) 50.84 58.62
Support Level $15.64 $31.03
Resistance Level $18.44 $36.63
Average True Range (ATR) 0.66 3.11
MACD -0.20 0.34
Stochastic Oscillator 19.64 51.84

Price Performance

Historical Comparison
PUBM
FTH

About PUBM PubMatic Inc.

PubMatic Inc is is an independent, artificial intelligence-powered advertising technology company that delivers digital advertising performance. Its integrated technology platform connects buyers, publishers, data providers, and commerce media networks on a single, unified platform, to deliver advertising performance, control, transparency and efficiency. Its platform empowers the world's digital content creators (publishers) to maximize monetization of their advertising inventory and audiences and provides control and transparency to buyers, which includes advertisers, agencies, agency trading desks, and demand side platforms (DSPs) (referred as buyers). Geographically, the company generates the majority of its revenue from the United States, followed by EMEA, APAC, and Rest of the World.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: